Custom Antibody Market Size to Surpass USD 444.66 Mn by 2033

The global custom antibody market size reached USD 175.70 million in 2023 and is projected to surpass around USD 444.66 million by 2033 with a significant CAGR of 9.73% from 2024 to 2033.

Key Points

  • The North America custom antibody market size reached USD 80.82 million in 2023 and is expected to attain around USD 206.77 million by 2033, poised to grow at a CAGR of 9.84% between 2024 and 2033.
  • North America dominated the market with the largest revenue share of 46% in 2023.
  • Asia Pacific is estimated to be the fastest-growing during the forecast period of 2024-2033.
  • By type, the monoclonal antibodies segment has contributed more than 51% of revenue share in 2023.
  • By type, the recombinant antibodies segment is expected to grow at a soldi CAGR of 11.93% during the forecast period.
  • By service, the antibody development segment has held a major revenue share of  55% in 2023.
  • By source, the rabbit segment has recorded more than 50% of revenue share in 2023.
  • By source, the mice segment is estimated to be the fastest-growing during the forecast period.
  • By application, the infectious disease segment has generated more than 28% of revenue share in 2023.
  • By application, the oncology segment is the fastest-growing during the forecast period.
  • By end-use, the academic research & institutes segment dominated has captured the biggest revenue share of 58% in 2023.
  • By end-use, the pharmaceutical & biotechnology companies segment is the fastest-growing during the forecast period.

Custom Antibody Market Size 2024 to 2033

The Custom Antibody Market is experiencing significant growth driven by advancements in biotechnology and increasing research activities across various sectors such as pharmaceuticals, biotechnology, and academic research. Custom antibodies are tailored to specific targets and are crucial tools in research, diagnostics, and therapeutics, offering high specificity and sensitivity. Key factors contributing to market expansion include rising demand for personalized medicine, technological innovations in antibody production methods like hybridoma and recombinant DNA technology, and growing investments in biopharmaceutical R&D. Moreover, the adoption of monoclonal antibodies for therapeutic applications further propels market growth, supported by their ability to target specific disease markers with minimal side effects. Geographically, North America and Europe dominate the market due to robust healthcare infrastructure and extensive research funding, while Asia-Pacific is witnessing rapid growth driven by increasing biotech investments and expanding healthcare initiatives.

Get a Sample: https://www.precedenceresearch.com/sample/4562

Custom Antibody Market Dynamics

Market Drivers

The Custom Antibody Market is driven by increasing demand for personalized medicine and targeted therapies across various medical fields. Custom antibodies play a crucial role in research, diagnostics, and therapeutic applications due to their specificity and high affinity for targeted antigens. Advances in biotechnology and genomics have significantly enhanced the development and customization of antibodies, enabling researchers and clinicians to tailor treatments to individual patient profiles. Moreover, rising investments in biopharmaceutical R&D and the growing prevalence of chronic diseases are further fueling market growth. These factors collectively drive the expansion of the custom antibody market worldwide.

Market Challenges

Despite its growth prospects, the Custom Antibody Market faces several challenges. One significant challenge is the high cost associated with custom antibody production and development. The process often involves complex procedures and requires specialized expertise, contributing to elevated production costs and pricing pressures. Moreover, maintaining consistency and quality in antibody production poses technical challenges, especially in scaling up production to meet growing demand. Additionally, regulatory complexities and ethical considerations surrounding antibody development and use present hurdles for market players navigating global healthcare regulatory frameworks.

Market Opportunities

The Custom Antibody Market presents promising opportunities driven by technological advancements and innovative applications. The advent of recombinant DNA technology and hybridoma techniques has revolutionized antibody production, enabling faster and more efficient customization of antibodies. Growing applications in personalized medicine, including biomarker discovery, disease diagnosis, and targeted therapeutics, open new avenues for market expansion. Furthermore, collaborations between pharmaceutical companies, research institutes, and academic centers are fostering innovation in antibody development and expanding the market landscape. Emerging markets in Asia-Pacific and Latin America offer untapped opportunities for market players to capitalize on increasing healthcare infrastructure development and research investments.

Custom Antibody Market Scope

Report Coverage Details
Market Size by 2033 USD 444.66 Million
Market Size in 2023 USD 175.70 Million
Market Size in 2024 USD 192.80 Million
Market Growth Rate from 2024 to 2033 CAGR of 9.73%
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Type, Service, Source, Application, End-use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read Also: Benzenoid Market Size to Hit USD 1,417.40 Million by 2033

Regional Insights

The Custom Antibody Market is experiencing robust growth globally, with North America and Europe leading in market share due to high research and development activities in biotechnology and pharmaceutical sectors. In North America, the market is driven by extensive investments in healthcare infrastructure and a strong presence of key market players. Europe benefits from significant government funding for life sciences research and the presence of prominent pharmaceutical companies. Asia-Pacific is rapidly growing, driven by increasing healthcare expenditure, expanding biotechnology industry, and rising demand for personalized medicine. Latin America and the Middle East & Africa regions are also witnessing growth, albeit at a slower pace, attributed to improving healthcare infrastructure and rising adoption of advanced medical technologies.

Type

The Custom Antibody Market includes both monoclonal and polyclonal antibodies. Monoclonal antibodies are derived from a single clone of cells and offer high specificity, making them ideal for targeted therapies and diagnostic applications requiring precise antigen recognition. Polyclonal antibodies, derived from multiple clones of cells, recognize multiple epitopes on an antigen, providing broader applications in techniques like Western blotting and immunohistochemistry.

Service

Services in the Custom Antibody Market encompass antibody production, purification, conjugation, and validation. Antibody production involves generating antibodies against specific antigens using techniques like hybridoma technology or recombinant DNA technology. Purification ensures the isolation of high-quality antibodies, while conjugation involves attaching molecules such as enzymes or fluorophores for various labeling and detection purposes. Validation confirms antibody specificity, affinity, and functionality through assays like ELISA and immunohistochemistry.

Source

Custom antibodies can be sourced from various organisms, including rabbits, mice, goats, and recombinant sources. Traditional sources such as rabbits and mice provide polyclonal antibodies through immunization protocols. Recombinant sources utilize engineered cells to produce antibodies with predefined characteristics, enhancing customization and scalability in biomanufacturing processes.

Application

Custom antibodies are widely applied in research, diagnostics, and therapeutics. In research, they facilitate protein characterization, biomarker discovery, and pathway analysis. Diagnostically, custom antibodies are pivotal for disease detection and monitoring through assays like ELISA and flow cytometry. Therapeutically, they are employed in targeted therapies for conditions such as cancer and autoimmune diseases, enhancing treatment efficacy while minimizing adverse effects on healthy tissues.

End-use

The Custom Antibody Market serves diverse end-users including academic and research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and contract research organizations (CROs). Academic institutions utilize custom antibodies for fundamental research and development of novel treatments. Pharmaceutical and biotechnology firms integrate custom antibodies into drug discovery and development pipelines, while diagnostic labs rely on them for accurate disease diagnosis and patient management.

Custom Antibody Market Companies

  • GenScript
  • LifeSpan BioSciences, Inc
  • Labcorp Drug Development
  • Abmart
  • YenZym Antibodies, LLC.
  • Kaneka Eurogentec S.A.
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • Creative Diagnostics
  • Thermo Fisher Scientific Inc.

Recent Developments

  • In October 2022, Absolute Biotech Company launched to offer antibody reagents, services, and expertise to researchers worldwide for therapeutic, diagnostic, and research applications. The company offers recombinant antibody expression, antibody engineering, custom antibody sequencing services, and more than one million off-the-shelf life science reagents.
  • In March 2024, a leading biotechnology company in genetic medicine, Agathos Biologics, launched its rAAV (recombinant adeno-associated virus) production service by using the company’s new AE1-BHK cell line. The company recorded its first sale of rAAV to a CRO/CMO (contract research and manufacturing organization), Genovac, that discovers, manufactures, and develops antibodies for research, therapeutics, and diagnostics market segments.

Segments Covered in the Report

By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Others

By Service

  • Antibody Development
  • Antibody Production & Purification
  • Antibody Fragmentation & Labeling

By Source

  • Mice
  • Rabbit
  • Others

By Application

  • Oncology
  • Infectious Diseases
  • Neurology
  • Stem Cells
  • Immunology
  • Cardiovascular Diseases
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CRO
  • Hospitals and Clinics

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/

Leave a Reply

Your email address will not be published. Required fields are marked *